NCT00340509View on ClinicalTrials.gov

A Genome-Wide Scan For Quantitative Trait Loci of Serum Bilirubin - A Framingham Study

CompletedOBSERVATIONAL
Enrollment

1,888

Participants

Timeline

Start Date

October 26, 2001

Study Completion Date

July 23, 2013

Conditions
Genetics
Trial Locations (1)

20892

National Heart, Lung and Blood Institute (NHLBI), 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00340509 - A Genome-Wide Scan For Quantitative Trait Loci of Serum Bilirubin - A Framingham Study | Biotech Hunter | Biotech Hunter